Transmissible Venereal Tumor - Literature Review

• Main Authors: T. R. B Berndt, A. C. R Rosa, A. K Kataoka
• Format: Article
• Language: English
• Published: Universidade Federal de Rondonópolis 2016-11-01
• Series: Scientific Electronic Archives
• Subjects: transmissible venereal tumor, cytology, vincristine
• Online Access: https://sea.ufr.edu.br/index.php?journal=SEA&page=article&op=view&path=246
• ISSN: 2316-9281; 2316-9281

Transmissible venereal tumor (TVT) is a contagious disease among the family of canines. Has a high prevalence in temperate regions and mainly affects male and female dogs wandering. Transmissible venereal tumor's main characteristic is a sexually transmitted cancer, through intercourse, and also transmitted through cell transplantation, an animal that has the disease to another Sound, which has an abrasion or epithelial discontinuity through licking or contact direct to neoplasia. It has no known etiology, although some authors suggest that there may be some virus as an agent. Is macroscopically observed as a crumbly mass, ulcerated, hemorrhagic, with the appearance of cauliflower. Their cells, if observed microscopically, have very clear, round and giant nucleus stained cytoplasm, and the presence of vacuolated cells in mitosis. The diagnosis can be accomplished by fine needle aspiration cytology, "imprint", histopathology, imaging tests such as x-ray and ultrasound, which are used for observation of metastases in internal organs. The main treatment is chemotherapy with substances such as vincristine dose of 0.5 to 0.7 mg / m², intra venous (IV), or from 0.0125 to 0.025 mg / kg IV once a week, four to eight weeks, and for animals which have acquired resistance to vincristine sulfate, is associated with the chemotherapeutic doxorubicin at a dose of 30 mg / m² IV once a week for four to eight weeks. Some protocols include prednisolone associated with vincristine sulfate for the treatment of Extragenital TVT.